Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research head

→ As Takeda celebrates a pair of FDA approvals, one of its top execs will be retiring in June 2027. Andy Plump joined Takeda from Sanofi in 2015, and has led R&D since December 2018 ...